Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by Slothman2on Mar 20, 2018 7:00pm
312 Views
Post# 27749935

RE:RE:RE:RE:Anyone else thinking of buying more in the $9.90 range?

RE:RE:RE:RE:Anyone else thinking of buying more in the $9.90 range? At no point was ACB going to be purchased, and no pharma company is going to bother dabbling in marijuana. If Apotex, Pfizer, Baxter, Actavis or any other giant pharma company that's valued higher than the entire MJ industry is in North America, and wanted to buy ANY of these MJ companies, they would have already done it. That isn't even a logical argument as to why anybody should sell their shares now. Misguided corporate strategy according to whom? You? So sell your shares if you have any, and stop posting on the ACB board, this place is of no use to you. You guys that short come on here and think you have some pull on what happens in the market by encouraging people to sell shares of a company that are fundamentally sound are ridiculous. Yes, parasitic, it's what that is. Marijuana is getting legalized, people are long on companies like aphria, canopy and aurora because of this and will see its true valuation in the coming years. Nobody cares about the price tag as it is in this moment. Get It, parasite?
schocor wrote: Parasite? Really? I will second ceakr123's opinion; if you have a profit take the money and run. If you have a loss, consider minimizing it by selling. What is the spark to take this higher? Aurora is now to expensive to be bought out by most MJ companies; and not cheap to the pharma companies. Oh - and they have a misguided corporate strategy, a lot of competition and an impaired investment in liquor stores.


Bullboard Posts